Skip to main content
Log in

The future of intrauterine contraception

  • Review Article
  • Published:
Advances in Contraception

Abstract

In this review paper some guidelines for IUD use are presented that if followed should reduce the incidence of IUD-related complications. Recent IUD developments are discussed including the levonorgestrel-releasing T, a new variation of the Multiload, and IUDs designed for postpartum insertion. Since significant improvements in IUD safety will most likely result from a better understanding of IUD-related side-effects and adverse reactions, the paper includes recommendations for future IUD research that could enhance the safety, effectiveness and acceptability of available IUDs.

Resumen

En esta revisión presentamos una serie de directrices que si se siguiesen reducirían significativamente la incidencia de las complicaciones referidas al uso del DIU. Actualmente se evestionan los recientes descubrimientos en torno al DIU, incluido el Levonorgestrel-T, una nueva variación del Multiload y DIUs indicados para la inserción postparto. Desde que se efectuaron importantes modificaciones en su utilización, hemos observado un incremento de su inocuidad y un descenso de los efectos indeseables, gracias principalmente a una utilización más oportuna. Ademas nos ha permitido comprener mejor los efectos colaterales relacionados con su uso. Incluimos tambien recomendaciones, para futuros trabajos, que pueden cambiar las directrices seguidas hasta ahora, mejorando la seguridad, efectividad y aceptabilidad de los DIUs.

Résumé

Dans cette communication d'ensemble sont présentés des conseils généraux relatifs à l'utilisation des DIU, qui devraient permettre, s'ils sont suivis, de réduire l'incidence des complications que ces dispositifs peuvent entraîner. Y sont examinés de récents progrès réalisés sur les DIU, et notamment sur le modèle T libérant du lévonorgestrel qui est une variante du modèle Multiload et des dispositifs conçus pour leur insertion après l'accouchement. Etant donné que toutes les améliorations importantes qui seront apportées du point de vue de la sécurité des DIU résulteront probablement d'une meilleure compréhension des effets secondaires et des réactions adverses imputables aux DIU, cette communications inclut des recommandations pour les recherches à venir, qui pourraient rehausser la sécurité, l'efficacité et l'acceptabilité des dispositifs actuellement sur le marché.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. TietzeC. (1978). What price fertility control? Lower than that of unwanted pregnancy. Contemp. OB-GYN,12 (1), 32

    Google Scholar 

  2. EdelmanD.A., BergerG.S. and KeithL.G. (1979). Intrauterine Devices And Their Complications. Boston: G.K. Hall & Co.

    Google Scholar 

  3. LanesS.F., PooleC., DreyerN.A. and LanzaL.L. (1986). Toxic shock syndrome, contraceptive methods and vaginitis. Am. J. Obstet. Gynecol.,154, 989

    PubMed  Google Scholar 

  4. SimpsonJ.L. (1985). Relationship between congenital anomalies and contraception. Adv. Contracept.,1, 3

    PubMed  Google Scholar 

  5. HassonH.M. (1985). Clinical experience with intrauterine devices in a private practice. Adv. Contracept.,1, 51

    PubMed  Google Scholar 

  6. HassonH.M. (1971). The Wing Sound: a new uterine measuring device. Obstet. Gynecol.,37, 915

    PubMed  Google Scholar 

  7. KurzK.H. (1985). Cavimeter uterine measurement and IUD clinical correlation. In: Intrauterine Contraception: Advances And Future Prospects, G.I.Zatuchni, A.Goldsmith, JJSciaara, eds., Philadelphia, Harper & Row, p. 142

    Google Scholar 

  8. van Os, W.A.A. (1987). The Multiload intrauterine device. Unpublished PhD thesis, University of Utrecht

  9. KochP., ReinhartP. and SoykaE. (1981). Intrauterine contraception using the Mini-Gravigard 7 IUD — summary of 328 case histories. Contracept. Deliv. Syst.,2, 171

    PubMed  Google Scholar 

  10. BatarI. (1985). Clinical experience with the MLCu250 IUD (eight-year results). Adv. Contracept.,1, 329

    PubMed  Google Scholar 

  11. ThieryM., van derPasH. and vanKetsH. (1985). The MLCu375 intrauterine contraceptive device. Adv. Contracept.,1, 37

    PubMed  Google Scholar 

  12. HaukkamaaM., AllonenH., HeikkilaM., LuukkainenT., LahteenmakiP., NilssonC.G. and ToivonenJ. (1985). Long-term clinical experience with levonorgestrel-releasing IUD. In: Intrauterine Contraception: Advances And Future Prospects, G.I.Zatuchni, J.J.Sciarra, eds., (Philadelphia, Harper & Row), p. 232

    Google Scholar 

  13. NilssonC.G., AllonenH., DiazJ. and LuukkainenT. (1983). Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. Fertil. Steril.,39, 187

    PubMed  Google Scholar 

  14. ColeL.P., EdelmanD.A., PottsD.M., WheelerR.G. and LaufeL.E. (1984). Postpartum insertion of modified intrauterine devices. J. Reprod. Med.,29, 677

    PubMed  Google Scholar 

  15. ThieryM. (1987). Intrauterine contraception: technical advances, future prospects. Network,8 (2), 1

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Os, W.A.A., Edelman, D.A. & Badrawi, H.H. The future of intrauterine contraception. Adv Contracept 3, 227–235 (1987). https://doi.org/10.1007/BF01849396

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849396

Keywords

Navigation